KMB

Kimberly-Clark Corporation
NASDAQCONSUMER DEFENSIVEHOUSEHOLD & PERSONAL PRODUCTS

Key Statistics

Market Cap
$35.82B
P/E Ratio
21.84
EPS
$4.94
Beta
0.28
52W High
$129.81
52W Low
$91.17
50-Day MA
$107.62
200-Day MA
$103.11
Dividend Yield
4.60%
Profit Margin
11.80%
Forward P/E
15.24
PEG Ratio
2.31

About Kimberly-Clark Corporation

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$16.58B
Gross Profit (TTM)$6.24B
EBITDA$3.48B
Operating Margin19.00%
Return on Equity104.90%
Return on Assets10.20%
Revenue/Share (TTM)$49.95
Book Value$5.26
Price-to-Book20.98
Price-to-Sales (TTM)2.16
EV/Revenue2.549
EV/EBITDA13.21
Quarterly Earnings Growth (YoY)-32.30%
Quarterly Revenue Growth (YoY)0.60%
Shares Outstanding$331.94M
Float$331.31M
% Insiders0.71%
% Institutions99.25%

Historical Volatility

HV 10-Day
32.00%
HV 20-Day
28.09%
HV 30-Day
29.08%
HV 60-Day
30.03%
HV Rank
76.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($118.60 target)
3
Strong Buy
3
Buy
9
Hold
1
Sell

Latest News

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

Accomplished legal executive and global litigator brings proven track record of enterprise risk management and strategic leadership to support Kimberly-Clark's next chapter of growth DALLAS, Aug. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) today announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will report to Jeff Melucci, Chief Strategy, Business Development and Administrative Officer, and will become a member of Kimberly-Clark's Executive Leadership Team.

PRNewsWire8/13/2026Neutral
Kimberly-Clark: Temporary Headwinds, Strong Innovation And Kenvue Synergies Support A Buy

Kimberly-Clark is rated Buy, supported by a strong innovation pipeline, international growth, and upside from the Kenvue acquisition. KMB faces transient headwinds in North America and China, but these are expected to abate, with management forecasting mid- to high-single-digit EPS CAGR from 2026–2028. The Kenvue deal will initially dilute EPS, but synergy realization is tracking ahead of plan, with $1.9B cost and $1.4B revenue synergy targets.

Seeking Alpha8/12/2026Negative
Kimberly-Clark: 'Buy' This Undervalued Dividend King Before Kenvue Closes

Kimberly-Clark remains a compelling value and income play, supported by strong brands and resilient consumer demand. KMB trades at a discounted 14.6x forward P/E with a well-covered 4.7% dividend yield and an "A" credit rating. Near-term headwinds include a China diaper controversy and Kenvue integration, but these risks appear priced in.

Seeking Alpha8/7/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KMB and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER DEFENSIVE Stocks

Data last updated: 8/18/2026